This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Desideri, G. Articles by Ferri, C. Search for Related Content PubMed PubMed Citation Articles by Desideri, G. Articles by Ferri, C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Antioxidants Cholesterol Hazardous Substances DB NITRIC OXIDE

Vitamin E Supplementation Reduces Plasma Vascular Cell Adhesion Molecule-1 and von Willebrand Factor Levels and Increases Nitric Oxide Concentrations in Hypercholesterolemic Patients

University of L’Aquila, Department of Internal Medicine and Public Health, 67100 Coppito-L’Aquila, Italy

Address all correspondence and requests for reprints to: Giovambattista Desideri, M.D., University of L’Aquila, Department of Internal Medicine and Public Health, Blocco 11, Via Vetoio, 67100 Coppito-L’Aquila, Italy. E-mail: . gbdesi{at}iol.it

Abstract

Up-regulation of vascular cell adhesion molecule-1 (VCAM-1) and reduced nitric oxide (NO) availability represent early characteristics of atherosclerosis. To evaluate whether the antioxidant vitamin E affected the circulating levels of soluble VCAM-1 (sVCAM-1) and the plasma metabolite of NO (nitrite+nitrate) in hypercholesterolemic patients, either vitamin E (either 400 IU or 800 IU/d for 8 wk) or placebo were randomly, double-blindly given to 36 hypercholesterolemic patients and 22 age- and sex-matched controls. At baseline hypercholesterolemic patients showed higher plasma sVCAM-1 (µg•liter^-1) (591.2 ± 132.5 vs. 505.0 ± 65.6, P < 0.007) and lower NO metabolite (µM) levels (15.9 ± 3.4 vs. 29.2 ± 5.1, P < 0.0001) than controls. In hypercholesterolemic patients, 8 wk vitamin E (but not placebo) treatment significantly decreased circulating sVCAM-1 levels (400 IU: -148.9 ± 84.6, P < 0.009; 800 IU: -204.0 ± 75.7, P < 0.0001; placebo: -4.7 ± 22.6, NS), whereas it increased NO metabolite concentrations (400 IU: +4.0 ± 1.7, P < 0.02; 800 IU: +5.5 ± 0.8, P < 0.0001; placebo: +0.1 ± 1.1, NS) without affecting circulating low- density lipoprotein levels. Changes in both plasma sVCAM-1 and NO metabolite levels showed a trend to significantly correlate (r = -0.515, P = 0.010; and r = 0.435, P = 0.034, respectively) with changes in vitamin E concentrations induced by vitamin E supplementation. In conclusion, isolated hypercholesterolemia both increased circulating sVCAM-1 and reduced NO metabolite concentrations. Vitamin E supplementation counteracts these alterations, thus representing a potential tool for endothelial protection in hypercholesterolemic patients.

This article has been cited by other articles:

				M. Negrean, A. Stirban, B. Stratmann, T. Gawlowski, T. Horstmann, C. Gotting, K. Kleesiek, M. Mueller-Roesel, T. Koschinsky, J. Uribarri, et al. Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1236 - 1243. [Abstract] [Full Text] [PDF]

				K. Nozaki, H. Hikiami, H. Goto, T. Nakagawa, N. Shibahara, and Y. Shimada Keishibukuryogan (Gui-Zhi-Fu-Ling-Wan), a Kampo Formula, Decreases Disease Activity and Soluble Vascular Adhesion Molecule-1 in Patients with Rheumatoid Arthritis Evid. Based Complement. Altern. Med., September 1, 2006; 3(3): 359 - 364. [Abstract] [Full Text] [PDF]

				A. Stirban, M. Negrean, B. Stratmann, T. Gawlowski, T. Horstmann, C. Gotting, K. Kleesiek, M. Mueller-Roesel, T. Koschinsky, J. Uribarri, et al. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care, September 1, 2006; 29(9): 2064 - 2071. [Abstract] [Full Text] [PDF]

				M. W Clarke, N. C Ward, J. H. Wu, J. M Hodgson, I. B Puddey, and K. D Croft Supplementation with mixed tocopherols increases serum and blood cell {gamma}-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes Am. J. Clinical Nutrition, January 1, 2006; 83(1): 95 - 102. [Abstract] [Full Text] [PDF]

				X. L. Wang, D. L Rainwater, M. C Mahaney, and R. Stocker Cosupplementation with vitamin E and coenzyme Q10 reduces circulating markers of inflammation in baboons Am. J. Clinical Nutrition, September 1, 2004; 80(3): 649 - 655. [Abstract] [Full Text] [PDF]

				K. Meksawan, D. R. Pendergast, J. J. Leddy, M. Mason, P. J. Horvath, and A. B. Awad Effect of Low and High Fat Diets on Nutrient Intakes and Selected Cardiovascular Risk Factors in Sedentary Men and Women J. Am. Coll. Nutr., April 1, 2004; 23(2): 131 - 140. [Abstract] [Full Text] [PDF]

				G. Desideri, G. Croce, M. Tucci, G. Passacquale, S. Broccoletti, L. Valeri, A. Santucci, and C. Ferri Effects of Bezafibrate and Simvastatin on Endothelial Activation and Lipid Peroxidation in Hypercholesterolemia: Evidence of Different Vascular Protection by Different Lipid-Lowering Treatments J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5341 - 5347. [Abstract] [Full Text] [PDF]

				M. M. Engler, M. B. Engler, M. J. Malloy, E. Y. Chiu, M. C. Schloetter, S. M. Paul, M. Stuehlinger, K. Y. Lin, J. P. Cooke, J. D. Morrow, et al. Antioxidant Vitamins C and E Improve Endothelial Function in Children With Hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial Circulation, September 2, 2003; 108(9): 1059 - 1063. [Abstract] [Full Text] [PDF]